LifeMD, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 38.61 million compared to USD 31.41 million a year ago. Net loss was USD 6.12 million compared to USD 7.28 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.26 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.26 a year ago.
For the nine months, revenue was USD 107.69 million compared to USD 90.91 million a year ago. Net loss was USD 16.86 million compared to USD 33.6 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 1.17 a year ago. Diluted loss per share from continuing operations was USD 0.58 compared to USD 1.17 a year ago.